London Eye turns green as a child-led PANS campaign enters the public eye
A 10-year-old campaigner from Oxfordshire has helped illuminate the London Eye in green to mark World PANS/PANDAS Awareness Day, turning a family struggle into a highly visible public-health message. The child, Albie, spent two years pressing for recognition of Paediatric Acute-onset Neuropsychiatric Syndrome and its subtype PANDAS, writing letters, speaking to public figures and reaching into institutions that rarely hear directly from families living with the condition. The landmark lighting on 10 October carried a simple but urgent message: sudden-onset psychiatric symptoms in children are not always a behavioral problem, and not every family navigating them is being heard.
His reaction was immediate and personal. “Seeing the London Eye turn green was amazing,” he said. “It made me feel like people were finally listening.”
The symbolism matters because PANS is often difficult for families to explain and even harder for outsiders to understand. It is described as a condition driven by a misdirected immune response that inflames a child’s brain, and that biological pathway helps explain why symptoms can appear abruptly and feel so destabilizing. Anxiety, aggressive behavior, depression and insomnia can emerge in a child who previously seemed well, creating a clinical picture that can be mistaken for purely psychiatric illness unless the underlying trigger is considered. Recognition by the World Health Organisation in 2018 gave the syndrome formal standing, but recognition does not automatically translate into awareness at the bedside, in schools, or across the wider health system.
One line in this story cuts through the pageantry: a child spent years trying to persuade adults that a real disorder was being missed.
A child’s campaign grew from one family’s crisis into national advocacy
Albie’s campaign began at age eight after he saw the impact of the illness on a family member. His mother, Megan, described the household as ordinary before the disorder changed its daily rhythm. “We are just a normal family who never asked to be in this position,” she said.
From there, the campaign grew with extraordinary speed for something led by a primary-school child. Albie wrote more than 150 letters, including messages to every children’s hospital in the country, NHS England executives and public figures. He also visited Parliament twice to press the issue, and the profile of his work rose when an MP shared the campaign in the House of Commons. The Deputy Speaker described him as a “superstar,” an unusual form of recognition for a child trying to make a rare condition visible.
The scale of the effort speaks to a common problem in disorders that sit at the edge of neurology, immunology and psychiatry. Families often become the coordinators of their own advocacy, translating symptoms into language that health systems can understand and repeating the same basic facts until someone responds. When a condition is unfamiliar, the burden of explanation shifts from clinician to parent, and then, in this case, even to a child. That is not a sustainable model of care, especially when symptoms can be frightening, disruptive and fast-moving.
Megan said the response to the campaign has started to change how isolated the family feels. “We no longer feel so alone. It feels like something is finally starting to change, and I could not be prouder of him,” she said.
Why PANS and PANDAS remain hard to spot in children
PANS and PANDAS are not everyday diagnoses in most clinical settings, and that rarity shapes how they are perceived. Their signature feature is abrupt onset. A child can develop severe anxiety, emotional lability, aggression, depression or sleep disturbance in a short time, often after an immune trigger. Because the presentation can look psychiatric first, the underlying inflammatory process may be overlooked, delayed or debated before it is recognized.
This is where public awareness intersects with clinical care. Earlier recognition can shorten the path to assessment, limit family uncertainty and reduce the risk that symptoms are treated as willful behavior rather than a medical syndrome. The disorder’s brain inflammation framework also helps explain why conventional reassurance alone is not enough when symptoms are intense. Parents are not describing a child who is merely anxious or acting out; they are describing a child whose behavior may have changed because the immune system has gone awry.
Albie’s use of the YouTube channel adds another layer to the campaign. It extends the message beyond a single landmark lighting and into a digital space where families, schools and health professionals can encounter the condition in plain language. For a little-known diagnosis, repetition matters. So does visibility. Green light on a national landmark does not change diagnosis on its own, but it can change who asks the question in the first place.
The London Eye display offered a striking public signal, yet the most important consequence may be quieter: more clinicians, teachers and parents may now have a name to attach to a cluster of symptoms they previously could not explain. For families living with PANS or PANDAS, that kind of recognition can alter the entire trajectory of care, even before any treatment decision is made.